Page last updated: 2024-08-16

ribavirin and Lassa Fever

ribavirin has been researched along with Lassa Fever in 65 studies

Research

Studies (65)

Timeframe	Studies, this research(%)	All Research%
pre-1990	13 (20.00)	18.7374
1990's	7 (10.77)	18.2507
2000's	10 (15.38)	29.6817
2010's	21 (32.31)	24.3611
2020's	14 (21.54)	2.80

Authors

Authors	Studies
Carroll, M; Duvignaud, A; Horby, PW; Jaspard, M; Malvy, D; Olliaro, PL; Salam, AP; Tarning, J	1
Gbelee, B; George, J; Jaryan, F; Jetoh, RW; MaCauley, J; Malik, S; Shobayo, B; Taweh, F; Teahton, J; Tegli, M; Umeokonkwo, CD; Yeabah, TO	1
Cheng, HY; Dawson, S; French, CE; Horby, PW; McAleenan, A; McGuinness, LA; Salam, AP; Savović, J; Sterne, JAC	1
Aihonwalan, L; Akhideno, P; Akhigbe, T; Babatunde, FO; Duraffour, S; Edeawe, O; Eifediyi, G; Erameh, C; Groger, M; Günther, S; Hinrichs, M; Hinzmann, J; Kleist, CJ; Koch, T; Müller, J; Nwatuzor, J; Oestereich, L; Ogbaini-Emovon, E; Okogbenin, S; Pahlmann, M; Ramharter, M; Riedner, M; Sarpong, FN; Thielebein, A; Wagner, C; Wicha, SG	1
Agho, J; Akhideno, P; Babatunde, FO; Edeawe, O; Ekuaze, E; Erameh, C; Groger, M; Günther, S; Iraoyah, K; Kreuels, B; Oestereich, L; Okoeguale, J; Okogbenin, S; Omansen, T; Ramharter, M	1
Agboeze, J; Ajayi, N; Chika-Igwenyi, N; Clement, CU; Eze, J; Kalombo, C; Makwe, C; Nnadozie, UU; Nwakpakpa, E; Nwali, MI; Nwidi, DU; Ogah, OE; Ojide, KC; Onoh, R; Orji, ML; Tshiang, J; Ukaegbe, C; Unigwe, SU	1
Adams, R; Brady, T; Cai, Y; Cheng, B; Cooper, K; de la Torre, JC; Hart, R; Iwasaki, M; Kuhn, JH; Kurtz, J; Liu, DX; Martínez-Sobrido, L; Nogales, A; Postnikova, EN; St Claire, M; Ye, C; Yu, S	1
Ellwanger, R; Goetsch, U; Gottschalk, R; Wetzstein, N; Wolf, T	1
Akhideno, P; Duraffour, S; Edeawe, O; Eifediyi, G; Erameh, C; Groger, M; Günther, S; Koch, T; Kurth, F; Oestereich, L; Ogbaini-Emovon, E; Okogbenin, S; Omansen, TF; Pahlmann, M; Ramharter, M; Sarpong, F; Wagner, C; Wicha, S	1
Abejegah, C; Amoo, OS; Audu, RA; Ayodeji, O; Ezechi, OC; Idigbe, I; Musa, AZ; Omilabu, SA; Salako, BL; Salu, OB; Shaibu, JO	1
Guedj, J; Lingas, G; Rosenke, K; Safronetz, D	1
Akabike, KO; Akano, A; Amedu, M; Bausch, DG; Bolt, H; Chandra, NL; Dan-Nwafor, C; Fagbemi, S; Ihekweazu, C; Ilori, E; Iniobong, A; Ipadeola, O; le Polain de Waroux, O; Namara, G; Newitt, S; Okhuarobo, U; Olayinka, AT; Sampson, E; Ukponu, W; Verlander, NQ	1
Abejegah, C; Abidoye, AT; Adedosu, AN; Ahmed, LA; Anglaret, X; Augier, A; Ayodeji, OO; Bérerd-Camara, M; Danet, N; Doutchi, M; Duraffour, S; Duvignaud, A; Etafo, IC; Gabillard, D; Günther, S; Horby, P; Jaspard, M; le Gal, C; Malvy, D; Ogbaini-Emovon, E; Owhin, S; Salam, AP; Schaeffer, J; Séri, B; Serra, B; Vihundira, JK	1
Onuh, JA; Uloko, AE	1
Cheng, V; Edwards, T; Horby, P; Olliaro, P; Salam, AP; Sterne, J	1
Akondy, RS; Cannon, D; Ellebedy, AH; Harmon, JR; Klena, JD; Kraft, CS; Lyon, MG; McElroy, AK; Mehta, AK; Nichol, ST; Ribner, BS; Sette, A; Sidney, J; Spiropoulou, CF; Varkey, JB	1
Carrillo-Bustamante, P; Graw, F; Guedj, J; Günther, S; Nguyen, THT; Oestereich, L	1
Becker, S; Brown, S; De Leuw, P; Eickmann, M; Faber, K; Kann, G; Klena, JD; Kraft, CS; Lyon, GM; McElroy, A; Mehta, AK; Morales, A; Nichol, S; Patel, K; Raabe, VN; Rabenau, H; Ribner, BS; Rollin, PE; Schuettfort, G; Stephan, C; Strecker, T; Ströher, U; Vanairsdale, S; Varkey, JB; Wolf, T	1
Ippolito, G; Nicastri, E; Vairo, F	1
Drenzek, C; Kraft, CS; O'Neal, JP; Raabe, V	1
Balogun, MS; Bashorun, AT; Bomoi, IM; Buba, MI; Dalhat, MM; Mohammad, JO; Nasidi, A; Nguku, PM; Nsubuga, P; Onwujei, J; Onyiah, AP; Waziri, N	1
Estébanez, M; Membrillo, FJ; Ramírez-Olivencia, G; Ybarra, MDC	1
Adé, S; Alassani, A; Attinsounon, CA; Dovonou, A; Glèlè Kakaï, C; Ossibi Ibara, BR; Saké, K	1
Eberhardt, KA; Groger, M; Günther, S; Jordan, S; Mischlinger, J; Ramharter, M	1
Akhuemokhan, OC; Akpede, GO; Dongo, AE; Iyamu, CE; Kesieme, EB; Okokhere, PO	1
Alders, P; Dahmane, A; Jambai, A; Nzomukunda, Y; Prior, J; Van den Bergh, R; van Griensven, J; Van Herp, M; Zachariah, R	1
Andersen, KG; Bausch, DG; Bishop, CM; Boisen, ML; Branco, LM; Brown, BL; Cross, RW; Elliot, DH; Folarin, OA; Fonnie, M; Fonnie, R; Fullah, M; Garry, RF; Geisbert, JB; Geisbert, TW; Geske, FJ; Gire, SK; Goba, A; Grant, DS; Haislip, AM; Happi, CT; Hartnett, JN; Hastie, KM; Henderson, LA; Illick, MM; Jones, AB; Kanneh, L; Kargbo, K; Khan, SH; Koroma, VJ; Kulakosky, PC; Levy, DC; Matschiner, A; Momoh, M; Moses, LM; Muncy, IJ; Ottomassathien, D; Pitts, KR; Robinson, JE; Sabeti, PC; Sampey, DB; Saphire, EO; Schieffelin, JS; Shaffer, JG; Spence, JS; Stremlau, M; Tabrizi, S; Tariyal, R; Wilson, RB; Yenni, RE; Zhu, H	1
Bausch, D; Blumberg, L; Dinh, TH; Duse, A; Paweska, J; Richards, G; Sewlall, NH; Swanepoel, R	1
Abilba, MM; Agbemaple, TK; Agbenohevi, PG; Ampofo, W; Bonney, JH; Kwawu, FK; Kyei, NN; Nimo-Paintsil, SC; Nyarko, EO; Ohene, SA	1
Feldmann, H; Furuta, Y; Geisbert, J; Geisbert, TW; Gowen, BB; Komeno, T; Martellaro, C; Okumura, A; Rosenke, K; Safronetz, D; Saturday, G; Westover, JB	1
Bockholt, S; Günther, S; Krasemann, S; Lüdtke, A; Muñoz-Fontela, C; Oestereich, L; Pallasch, E; Rieger, T; Ruibal, P; Wurr, S	1
de la Torre, JC	1
Bausch, DG; Hadi, CM; Khan, SH; Lertora, JJ	1
Bah, A; Bangura, J; Bausch, DG; Coulibaly, M; Goba, A; Hadi, CM; Juana, B; Khan, SH; Koroma, S; Sankoh, M	1
Andersen, KG; Bangura, JJ; Boisen, ML; Branco, LM; Fonnie, M; Garry, RF; Grant, DS; Grove, JN; Henderson, LA; Moses, LM; Muncy, IJ; Raabe, VN; Robinson, JE; Sabeti, PC; Schieffellin, JS; Zaitsev, EM	1
Adomeh, DI; Akhuemokhan, OC; Akpede, GO; Alikah, SO; Andersen, K; Asogun, DA; Becker-Ziaja, B; Dongo, A; Ehiane, PE; Ehimuan, J; Folarin, O; Gabriel, M; Gire, S; Günther, S; Happi, CT; Hass, M; Ifeh, VE; Imomeh, P; Momoh, M; Muoebonam, EB; Odia, I; Odike, MA; Okogbenin, SA; Okokhere, PO; Oladapo, YT; Olschläger, S; Osunde, O; Phelan, E; Sabeti, PC; Uyigue, EA	1
Schippers, EF; Veldkamp, PJ	1
Asper, M; Breuer, T; Drosten, C; Emmerich, P; Fleischer, K; Gölnitz, U; Günther, S; Haas, WH; Köhler, P; Pfaff, G; Schmitz, H	1
Fisher-Hoch, SP; McCormick, JB	2
Bausch, DG; Chu, M; Fair, J; Ferro, P; Garry, RF; Goba, A; Guttieri, MC; Healing, T; Imes, T; Khan, SH; Marx, A; Monagin, C; Roth, C	1
Jahrling, PB; Peters, CJ; Stephen, EL	1
Callis, RT; Eddy, GA; Hesse, RA; Jahrling, PB; Johnson, KM; Stephen, EL	1
Canonico, PG; Stephen, EL; Wannarka, GL	1
Hirabayashi, Y	1
Fleischer, K; Kirchner, A; Köhler, B; Schmid, J	1
ter Meulen, J	1
Aldis, W; Kaushik, SK; Koivogui, L; Lenz, O; Lewis, R; Magassouba, N; ter Meulen, J	1
Birmingham, K; Kenyon, G	1
Beersma, MF; Drosten, C; Emmerich, P; Fleischer, K; Geisen, HP; Günther, S; Hoerauf, A; Köhler, B; Laue, T; Schmitz, H; Veldkamp, PJ	1
Jahrling, PB; Stephen, EL	1
Nzerue, MC	1
Fisher-Hoch, SP; Gborie, S; Huggins, J; Parker, L	1
Bannister, B	1
Cummins, D	1
Brammer, LS; Chase, RA; Hall, PA; Holmes, GP; Lewis, SM; Mason, CA; McCormick, JB; McDonnell, MK; Perez-Oronoz, GI; Trock, SC	1
Johnson, KM; Monath, TP	1
Banks, G; Fernandez, H; Smith, R	1
Barrera Oro, JG; Jahrling, PB; Kenyon, RH; Liu, CT; McKee, KT; Peters, CJ	1
Craven, RB; Fisher-Hoch, S; McCormick, JB; Sasso, D	1
Snell, N	1
McCormick, JB	1
Monath, TP	1
Belmont-Williams, R; Craven, RB; Elliott, LH; Johnson, KM; King, IJ; McCormick, JB; Scribner, CL; Webb, PA	1

Reviews

13 review(s) available for ribavirin and Lassa Fever

Article	Year
Ribavirin for treating Lassa fever: A systematic review of pre-clinical studies and implications for human dosing. PLoS neglected tropical diseases, 2022, Volume: 16, Issue:3 Topics: Antiviral Agents; Humans; Lassa Fever; Lassa virus; Research Design; Ribavirin; Virus Replication	2022
Lack of Evidence for Ribavirin Treatment of Lassa Fever in Systematic Review of Published and Unpublished Studies Emerging infectious diseases, 2022, Volume: 28, Issue:8 Topics: Africa, Western; Humans; Lassa Fever; Lassa virus; Ribavirin; Sierra Leone	2022
Fifty years of imported Lassa fever: a systematic review of primary and secondary cases. Journal of travel medicine, 2020, Jul-14, Volume: 27, Issue:4 Topics: Africa, Western; Humans; Lassa Fever; Public Health; Retrospective Studies; Ribavirin	2020
Use of ribavirin in viruses other than hepatitis C. A review of the evidence. Enfermedades infecciosas y microbiologia clinica (English ed.), 2019, Volume: 37, Issue:9 Topics: Adenoviridae Infections; Adenoviruses, Human; Antiviral Agents; Arenaviruses, New World; Clinical Trials as Topic; Coronavirus Infections; Hantavirus Infections; Hemorrhagic Fever Virus, Crimean-Congo; Hemorrhagic Fever, American; Hemorrhagic Fever, Crimean; Humans; Lassa Fever; Lassa virus; Meta-Analysis as Topic; Middle East Respiratory Syndrome Coronavirus; Orthohantavirus; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Ribavirin; Virus Diseases; Viruses	2019
Ribavirin for the treatment of Lassa fever: A systematic review and meta-analysis. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2019, Volume: 87 Topics: Aspartate Aminotransferases; Clinical Trials as Topic; Humans; Lassa Fever; Lassa virus; Prospective Studies; Retrospective Studies; Ribavirin	2019
Review of the literature and proposed guidelines for the use of oral ribavirin as postexposure prophylaxis for Lassa fever. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2010, Dec-15, Volume: 51, Issue:12 Topics: Antiviral Agents; Chemoprevention; Humans; Lassa Fever; Practice Guidelines as Topic; Ribavirin	2010
Lassa fever vaccine. Expert review of vaccines, 2004, Volume: 3, Issue:2 Topics: Africa, Western; Animals; Antiviral Agents; Humans; Lassa Fever; Lassa virus; Ribavirin; Viral Vaccines	2004
New opportunities for field research on the pathogenesis and treatment of Lassa fever. Antiviral research, 2008, Volume: 78, Issue:1 Topics: Adolescent; Adult; Africa, Western; Antiviral Agents; Child, Preschool; Female; Humans; Incidence; Infant, Newborn; Lassa Fever; Lassa virus; Male; Pregnancy; Research; Ribavirin	2008
[Lassa fever: its virological and clinical aspects]. Ryoikibetsu shokogun shirizu, 1999, Issue:23 Pt 1 Topics: Antiviral Agents; Diagnosis, Differential; Humans; Lassa Fever; Ribavirin; RNA Viruses	1999
Lassa fever: immuno-epidemiological approach to the study of an endemic viral haemorrhagic fever. Medecine tropicale : revue du Corps de sante colonial, 2000, Volume: 60, Issue:2 Suppl Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Antiviral Agents; Disease Models, Animal; Disease Vectors; Endemic Diseases; Female; Humans; Lassa Fever; Male; Middle Aged; Muridae; Ribavirin; T-Lymphocytes; Tropical Medicine	2000
Lassa fever: review of virology, immunopathogenesis, and algorithms for control and therapy. The Central African journal of medicine, 1992, Volume: 38, Issue:6 Topics: Algorithms; Antibodies, Viral; Clinical Protocols; Diagnosis, Differential; Fluid Therapy; Humans; Immunoglobulin G; Immunoglobulin M; Lassa Fever; Prognosis; Ribavirin	1992
Lassa fever. British journal of hospital medicine, 1990, Volume: 43, Issue:3 Topics: Africa, Western; Humans; Lassa Fever; Ribavirin	1990
Ribavirin: a clinical overview. European journal of epidemiology, 1986, Volume: 2, Issue:1 Topics: Clinical Trials as Topic; Hepatitis, Viral, Human; Herpesviridae Infections; Humans; Influenza, Human; Kinetics; Lassa Fever; Measles; Respiratory Syncytial Viruses; Respirovirus Infections; Ribavirin; Ribonucleosides; Virus Diseases	1986

Trials

2 trial(s) available for ribavirin and Lassa Fever

Article	Year
Unexpected adverse reactions during a clinical trial in rural west Africa. Antiviral research, 1992, Volume: 19, Issue:2 Topics: Humans; Injections, Intravenous; Lassa Fever; Retrospective Studies; Ribavirin; Sierra Leone	1992
Ribavirin: a clinical overview. European journal of epidemiology, 1986, Volume: 2, Issue:1 Topics: Clinical Trials as Topic; Hepatitis, Viral, Human; Herpesviridae Infections; Humans; Influenza, Human; Kinetics; Lassa Fever; Measles; Respiratory Syncytial Viruses; Respirovirus Infections; Ribavirin; Ribonucleosides; Virus Diseases	1986

Other Studies

51 other study(ies) available for ribavirin and Lassa Fever

Article	Year
Epidemiological characteristics of Lassa fever cases in Liberia: a retrospective analysis of surveillance data, 2019-2020. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2022, Volume: 122 Topics: Child; Humans; Lassa Fever; Lassa virus; Liberia; Public Health; Retrospective Studies; Ribavirin	2022
Pharmacokinetics of Ribavirin in the Treatment of Lassa Fever: An Observational Clinical Study at the Irrua Specialist Teaching Hospital, Edo State, Nigeria. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2023, 02-08, Volume: 76, Issue:3 Topics: Antiviral Agents; Female; Hospitals, Teaching; Humans; Lassa Fever; Male; Nigeria; Prospective Studies; Ribavirin	2023
Two Cases of Lassa Fever Successfully Treated with Ribavirin and Adjunct Dexamethasone for Concomitant Infections. Emerging infectious diseases, 2022, Volume: 28, Issue:10 Topics: Antiviral Agents; Dexamethasone; Humans; Lassa Fever; Lassa virus; Ribavirin	2022
Lassa fever in pregnancy with a positive maternal and fetal outcome: A case report. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2019, Volume: 89 Topics: Adult; Antiviral Agents; Female; Fever; Humans; Infant, Newborn; Lassa Fever; Lassa virus; Male; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Ribavirin	2019
A Lassa Fever Live-Attenuated Vaccine Based on Codon Deoptimization of the Viral Glycoprotein Gene. mBio, 2020, 02-25, Volume: 11, Issue:1 Topics: A549 Cells; Africa, Western; Amino Acid Sequence; Animals; Arenaviridae; Arenavirus; Bunyaviridae; Chlorocebus aethiops; Codon; Disease Models, Animal; Female; Genes, Viral; Genome, Viral; Glycoproteins; Guinea Pigs; Humans; Lassa Fever; Lassa virus; Male; Ribavirin; Vaccines, Attenuated; Vero Cells; Viral Vaccines	2020
Prospective observational study on the pharmacokinetic properties of the Irrua ribavirin regimen used in routine clinical practice in patients with Lassa fever in Nigeria. BMJ open, 2020, 04-16, Volume: 10, Issue:4 Topics: Adult; Humans; Lassa Fever; Nigeria; Observational Studies as Topic; Prospective Studies; Research Design; Ribavirin	2020
Monitoring of Lassa virus infection in suspected and confirmed cases in Ondo State, Nigeria. The Pan African medical journal, 2020, Volume: 36 Topics: Adult; Antiviral Agents; Cross-Sectional Studies; Disease Outbreaks; Female; Humans; Lassa Fever; Lassa virus; Male; Middle Aged; Milk, Human; Nigeria; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin; Semen	2020
Lassa viral dynamics in non-human primates treated with favipiravir or ribavirin. PLoS computational biology, 2021, Volume: 17, Issue:1 Topics: Amides; Animals; Antiviral Agents; Female; Host-Pathogen Interactions; Lassa Fever; Lassa virus; Macaca fascicularis; Models, Biological; Pyrazines; Ribavirin; Viral Load	2021
Factors associated with delayed presentation to healthcare facilities for Lassa fever cases, Nigeria 2019: a retrospective cohort study. BMC infectious diseases, 2021, Feb-04, Volume: 21, Issue:1 Topics: Adolescent; Adult; Antiviral Agents; Child; Child, Preschool; Cohort Studies; Female; Humans; Infant; Lassa Fever; Male; Middle Aged; Nigeria; Proportional Hazards Models; Retrospective Studies; Ribavirin; Time-to-Treatment; Young Adult	2021
Lassa fever outcomes and prognostic factors in Nigeria (LASCOPE): a prospective cohort study. The Lancet. Global health, 2021, Volume: 9, Issue:4 Topics: Administration, Intravenous; Adolescent; Adult; Age Factors; Child; Child, Preschool; DNA, Viral; Female; Follow-Up Studies; Hospital Mortality; Hospitalization; Humans; Infant; Infant, Newborn; Kaplan-Meier Estimate; Lassa Fever; Lassa virus; Male; Middle Aged; Nigeria; Palliative Care; Pregnancy; Prognosis; Prospective Studies; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin; Risk Factors; Severity of Illness Index; Time Factors; Treatment Outcome; Young Adult	2021
Favourable Outcome of Severe Lassa Fever Following Early Diagnosis and Treatment: A Case Report. West African journal of medicine, 2021, Apr-23, Volume: 38, Issue:4 Topics: Adult; Fever; Humans; Lassa Fever; Male; Nigeria; Ribavirin	2021
Time to reconsider the role of ribavirin in Lassa fever. PLoS neglected tropical diseases, 2021, Volume: 15, Issue:7 Topics: Antiviral Agents; Humans; Lassa Fever; Ribavirin	2021
A Case of Human Lassa Virus Infection With Robust Acute T-Cell Activation and Long-Term Virus-Specific T-Cell Responses. The Journal of infectious diseases, 2017, 06-15, Volume: 215, Issue:12 Topics: Adult; Amides; Antibodies, Viral; Antigens, Viral; Antiviral Agents; CD8-Positive T-Lymphocytes; Enzyme-Linked Immunosorbent Assay; Humans; Immunity, Cellular; Immunoglobulin Class Switching; Lassa Fever; Lassa virus; Lymphocyte Activation; Male; Pyrazines; Ribavirin; Viremia	2017
Determining Ribavirin's mechanism of action against Lassa virus infection. Scientific reports, 2017, 09-15, Volume: 7, Issue:1 Topics: Amides; Animals; Antiviral Agents; Disease Models, Animal; Drug Therapy, Combination; Lassa Fever; Lassa virus; Mice, Inbred C57BL; Models, Theoretical; Pyrazines; Ribavirin; Treatment Outcome; Viral Load	2017
Favipiravir and Ribavirin Treatment of Epidemiologically Linked Cases of Lassa Fever. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017, Sep-01, Volume: 65, Issue:5 Topics: Adult; Amides; Antiviral Agents; Humans; Lassa Fever; Lassa virus; Male; Polymerase Chain Reaction; Pyrazines; Ribavirin; RNA, Viral; Togo	2017
Discharge Criteria for Patient With Lassa Fever Infection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2018, 02-01, Volume: 66, Issue:4 Topics: Amides; Humans; Lassa Fever; Patient Discharge; Pyrazines; Ribavirin	2018
Reply to Nicastri et al. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2018, 02-01, Volume: 66, Issue:4 Topics: Amides; Humans; Lassa Fever; Pyrazines; Ribavirin	2018
Mortality Among Confirmed Lassa Fever Cases During the 2015-2016 Outbreak in Nigeria. American journal of public health, 2018, Volume: 108, Issue:2 Topics: Adult; Antiviral Agents; Disease Outbreaks; Humans; Lassa Fever; Nigeria; Population Surveillance; Prevalence; Retrospective Studies; Ribavirin	2018
Report of a fatal case of Lassa fever in Parakou in 2018: clinical, therapeutic and diagnostic aspects. BMC infectious diseases, 2018, Dec-17, Volume: 18, Issue:1 Topics: Adult; Anti-Bacterial Agents; Benin; Delayed Diagnosis; Fatal Outcome; Humans; Lassa Fever; Lassa virus; Male; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin	2018
Lassa fever presenting as acute abdomen: a case series. Virology journal, 2013, Apr-19, Volume: 10 Topics: Abdomen, Acute; Adolescent; Adult; Africa, Western; Antiviral Agents; Diagnosis, Differential; Fatal Outcome; Female; Humans; Infant; Lassa Fever; Male; Ribavirin; Young Adult	2013
Constraints in the diagnosis and treatment of Lassa Fever and the effect on mortality in hospitalized children and women with obstetric conditions in a rural district hospital in Sierra Leone. Transactions of the Royal Society of Tropical Medicine and Hygiene, 2014, Volume: 108, Issue:3 Topics: Adolescent; Adult; Antiviral Agents; Child; Child, Preschool; Clinical Audit; Disease Management; Female; Hospital Mortality; Hospitals, District; Humans; Infant; Lassa Fever; Male; Ribavirin; Rural Population; Sierra Leone; Time Factors; Young Adult	2014
Lassa fever in post-conflict sierra leone. PLoS neglected tropical diseases, 2014, Volume: 8, Issue:3 Topics: Adolescent; Adult; Age Factors; Antibodies, Viral; Antigens, Viral; Child; Child, Preschool; Female; Humans; Immunoassay; Incidence; Infant; Lassa Fever; Lassa virus; Male; Pregnancy; Pregnancy Complications, Infectious; Ribavirin; Seasons; Sierra Leone; Survival Analysis; Young Adult	2014
Clinical features and patient management of Lujo hemorrhagic fever. PLoS neglected tropical diseases, 2014, Volume: 8, Issue:11 Topics: Acetylcysteine; Adult; Antiviral Agents; Arenaviridae Infections; Cross Infection; Disease Outbreaks; Factor VIIa; Fatal Outcome; Female; Hemorrhagic Fevers, Viral; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lassa Fever; Lassa virus; Lujo virus; Male; Middle Aged; Recombinant Proteins; Ribavirin; South Africa	2014
Imported Lassa fever: a report of 2 cases in Ghana. BMC infectious diseases, 2015, May-29, Volume: 15 Topics: Adult; Antiviral Agents; Communicable Diseases, Emerging; Contact Tracing; Ghana; Humans; Lassa Fever; Lassa virus; Liberia; Male; Military Personnel; Public Health; Ribavirin; Travel	2015
The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset. Scientific reports, 2015, Oct-12, Volume: 5 Topics: Amides; Animals; Animals, Outbred Strains; Antibodies, Viral; Antiviral Agents; Drug Administration Schedule; Drug Dosage Calculations; Guinea Pigs; Humans; Immunoglobulin G; Lassa Fever; Lassa virus; Liver; Lung; Male; Pyrazines; Ribavirin; Spleen; Survival Analysis; Viral Load	2015
Efficacy of Favipiravir Alone and in Combination With Ribavirin in a Lethal, Immunocompetent Mouse Model of Lassa Fever. The Journal of infectious diseases, 2016, Mar-15, Volume: 213, Issue:6 Topics: Amides; Animals; Antiviral Agents; Chlorocebus aethiops; Drug Therapy, Combination; Lassa Fever; Mice; Pyrazines; Ribavirin; Vero Cells; Viral Load; Virus Replication	2016
Molecular and cell biology of the prototypic arenavirus LCMV: implications for understanding and combating hemorrhagic fever arenaviruses. Annals of the New York Academy of Sciences, 2009, Volume: 1171 Suppl 1 Topics: Animals; Antiviral Agents; Arenaviridae; Arenaviridae Infections; Bioterrorism; Disease Models, Animal; Genome, Viral; Humans; Lassa Fever; Lassa virus; Lymphocytic Choriomeningitis; Lymphocytic choriomeningitis virus; Ribavirin; RNA, Viral; United States; Viral Vaccines	2009
Ribavirin for Lassa fever postexposure prophylaxis. Emerging infectious diseases, 2010, Volume: 16, Issue:12 Topics: Administration, Oral; Adult; Aged; Antiviral Agents; Female; Follow-Up Studies; Humans; Lassa Fever; Male; Medication Adherence; Middle Aged; Post-Exposure Prophylaxis; Retrospective Studies; Ribavirin; Sierra Leone	2010
Lassa hemorrhagic fever in a late term pregnancy from northern Sierra Leone with a positive maternal outcome: case report. Virology journal, 2011, Aug-15, Volume: 8 Topics: Antibodies, Viral; Antigens, Viral; Case-Control Studies; Cytokines; Female; Fetal Death; Genetic Variation; Humans; Immunoassay; Injections, Intravenous; Lassa Fever; Lassa virus; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Third; Public Health; Ribavirin; RNA, Viral; Sierra Leone; Young Adult	2011
Molecular diagnostics for lassa fever at Irrua specialist teaching hospital, Nigeria: lessons learnt from two years of laboratory operation. PLoS neglected tropical diseases, 2012, Volume: 6, Issue:9 Topics: Adolescent; Adult; Antiviral Agents; Female; Hospitals, Teaching; Humans; Lassa Fever; Lassa virus; Male; Middle Aged; Molecular Diagnostic Techniques; Molecular Sequence Data; Nigeria; Polymerase Chain Reaction; Ribavirin; RNA, Viral; Sequence Analysis, DNA; Survival Analysis; Young Adult	2012
[A man with fatal Lassa fever following a stay in Sierra Leone]. Nederlands tijdschrift voor geneeskunde, 2002, Nov-16, Volume: 146, Issue:46 Topics: Antiviral Agents; Fatal Outcome; Humans; Lassa Fever; Lassa virus; Male; Middle Aged; Netherlands; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin; RNA, Viral; Sierra Leone; Travel	2002
Imported Lassa fever in Germany: surveillance and management of contact persons. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2003, May-15, Volume: 36, Issue:10 Topics: Animals; Antibodies, Viral; Antiviral Agents; Chemoprevention; Germany; Humans; Immunoglobulin G; Lassa Fever; Lassa virus; Ribavirin; Risk Management	2003
Management of Lassa fever. Lancet (London, England), 1984, Sep-29, Volume: 2, Issue:8405 Topics: Animals; Humans; Immunization, Passive; Lassa Fever; Ribavirin	1984
Enhanced treatment of Lassa fever by immune plasma combined with ribavirin in cynomolgus monkeys. The Journal of infectious diseases, 1984, Volume: 149, Issue:3 Topics: Animals; Antibodies, Viral; Combined Modality Therapy; Immunization, Passive; Lassa Fever; Lassa virus; Macaca fascicularis; Male; Ribavirin; Ribonucleosides; Time Factors; Viremia	1984
Lassa virus infection of rhesus monkeys: pathogenesis and treatment with ribavirin. The Journal of infectious diseases, 1980, Volume: 141, Issue:5 Topics: Adrenal Glands; Alanine Transaminase; Animals; Antibodies, Viral; Antigens, Viral; Antiviral Agents; Aspartate Aminotransferases; Fluorescent Antibody Technique; Haplorhini; Lassa Fever; Leukopenia; Liver; Lymph Nodes; Macaca mulatta; Macrophages; Platelet Count; Ribavirin; Ribonucleosides; Spleen; Virus Replication	1980
Preclinical evaluation of monkeys of a ribavirin regimen proposed for use in Lassa fever patients. Toxicology and applied pharmacology, 1982, Jun-15, Volume: 64, Issue:1 Topics: Animals; Drug Administration Schedule; Drug Evaluation, Preclinical; Erythrocyte Count; Female; Hematocrit; Hemoglobinometry; Lassa Fever; Leukocyte Count; Lymphocytes; Macaca mulatta; Male; Platelet Count; Reticulocytes; Ribavirin; Ribonucleosides	1982
[Lassa fever]. Medizinische Klinik (Munich, Germany : 1983), 2000, Jun-15, Volume: 95, Issue:6 Topics: Adult; Africa, Western; Antiviral Agents; Critical Care; Diagnosis, Differential; Fatal Outcome; Female; Germany; Humans; Lassa Fever; Lassa virus; Patient Isolation; Polymerase Chain Reaction; Ribavirin; Travel	2000
Short communication: Lassa fever in Sierra Leone: UN peacekeepers are at risk. Tropical medicine & international health : TM & IH, 2001, Volume: 6, Issue:1 Topics: Adult; Antiviral Agents; Humans; Lassa Fever; Male; Ribavirin; Risk; Sierra Leone; United Nations	2001
Lassa fever is unheralded problem in West Africa. Nature medicine, 2001, Volume: 7, Issue:8 Topics: Animals; Antiviral Agents; Humans; Lassa Fever; Liberia; Primates; Ribavirin; Sierra Leone; United Kingdom; Vaccines, Synthetic	2001
Monitoring of clinical and laboratory data in two cases of imported Lassa fever. Microbes and infection, 2002, Volume: 4, Issue:1 Topics: Adult; Africa; Antibodies, Viral; Antiviral Agents; Cytokines; Fatal Outcome; Female; Humans; Lassa Fever; Lassa virus; Male; Middle Aged; Ribavirin; RNA, Viral; Travel; Viral Load; Viremia	2002
Experimental Lassa fever virus infection successfully treated with ribavirin. Lancet (London, England), 1979, Feb-03, Volume: 1, Issue:8110 Topics: Animals; Drug Evaluation; Haplorhini; Injections, Intramuscular; Lassa Fever; Macaca mulatta; Ribavirin; Ribonucleosides	1979
Lassa fever. BMJ (Clinical research ed.), 1991, Jan-12, Volume: 302, Issue:6768 Topics: Animals; Cross Infection; Humans; Lassa Fever; Ribavirin	1991
Lassa fever in the United States. Investigation of a case and new guidelines for management. The New England journal of medicine, 1990, Oct-18, Volume: 323, Issue:16 Topics: Adult; Algorithms; Clinical Protocols; Communicable Disease Control; Critical Care; Humans; Illinois; Lassa Fever; Male; Population Surveillance; Ribavirin; Risk Factors; United States	1990
Imported Lassa fever--reexamining the algorithms. The New England journal of medicine, 1990, Oct-18, Volume: 323, Issue:16 Topics: Administration, Oral; Algorithms; Humans; Lassa Fever; Male; Ribavirin	1990
Experimental studies of arenaviral hemorrhagic fevers. Current topics in microbiology and immunology, 1987, Volume: 134 Topics: Animals; Arenaviridae; Arenaviridae Infections; Cricetinae; Disease Models, Animal; Guinea Pigs; Haplorhini; Hemorrhagic Fever, American; Hemorrhagic Fevers, Viral; Immune Tolerance; Lassa Fever; Lymphocytic Choriomeningitis; Mice; Ribavirin	1987
Hematologic dysfunction in Lassa fever. Journal of medical virology, 1988, Volume: 26, Issue:2 Topics: Humans; Lassa Fever; Leukocyte Count; Lymphocytes; Platelet Aggregation; Platelet Count; Prospective Studies; Ribavirin; Thrombocytopenia	1988
Ribavirin therapy for lassa fever. The Practitioner, 1988, Apr-22, Volume: 232, Issue:1447 Topics: Animals; Humans; Lassa Fever; Macaca mulatta; Ribavirin; Ribonucleosides	1988
Pathophysiology and treatment of Lassa fever. Current topics in microbiology and immunology, 1987, Volume: 134 Topics: Animals; Blood Platelets; Humans; Lassa Fever; Microcirculation; Ribavirin; Viral Vaccines	1987
Clinical, epidemiologic, and therapeutic aspects of Lassa fever. Medical microbiology and immunology, 1986, Volume: 175, Issue:2-3 Topics: Adult; Animals; Antibodies, Viral; Disease Outbreaks; Disease Vectors; Female; Humans; Immunization, Passive; Lassa Fever; Lassa virus; Male; Muridae; Prospective Studies; Ribavirin; Sierra Leone	1986
Lassa fever--new issues raised by field studies in West Africa. The Journal of infectious diseases, 1987, Volume: 155, Issue:3 Topics: Africa, Western; Genes, Viral; Humans; Lassa Fever; Lassa virus; Prognosis; Ribavirin; Sierra Leone; Viremia; Virulence	1987
Lassa fever. Effective therapy with ribavirin. The New England journal of medicine, 1986, Jan-02, Volume: 314, Issue:1 Topics: Administration, Oral; Adult; Antibodies, Viral; Aspartate Aminotransferases; Drug Evaluation; Humans; Immunization, Passive; Injections, Intravenous; Lassa Fever; Lassa virus; Random Allocation; Ribavirin; Ribonucleosides; Time Factors; Viremia	1986